These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1492579)

  • 1. Progesterone administration by nasal spray in menopausal women: comparison between two different spray formulations.
    Cicinelli E; Savino F; Cagnazzo I; Scorcia P; Galantino P
    Gynecol Endocrinol; 1992 Dec; 6(4):247-51. PubMed ID: 1492579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasally-administered progesterone: comparison of ointment and spray formulations.
    Cicinelli E; Ragno G; Cagnazzo I; Fanelli F; Vetuschi C; Cantatore FP
    Maturitas; 1991 Oct; 13(4):313-7. PubMed ID: 1775083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of progesterone plasma levels after nasal spray and intramuscular administration of natural progesterone in menopausal women.
    Cicinelli E; Savino F; Cagnazzo I; Scorcia P
    Gynecol Obstet Invest; 1993; 35(3):172-4. PubMed ID: 8505011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone administration by nasal spray.
    Cicinelli E; Ragno G; Cagnazzo I; Fanelli F; Vetuschi C; Schonauer S
    Fertil Steril; 1991 Jul; 56(1):139-41. PubMed ID: 2065793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of unmodified progesterone by nasal spray in fertile women.
    Cicinelli E; Nahoul K; Sabatelli S; Petruzzi D; Lapenna M; Scorcia P; Schönauer LM
    Gynecol Endocrinol; 1995 Dec; 9(4):289-93. PubMed ID: 8629456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal spray administration of unmodified progesterone: evaluation of progesterone serum levels with three different radioimmunoassay techniques.
    Cicinelli E; Nahoul K; Petruzzi D; Galantino P; Santoro G
    Maturitas; 1994 May; 19(1):43-52. PubMed ID: 7935031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of intranasal formulations of dihydroergotamine.
    van der Kuy PH; Lohman JJ; Hooymans PM; Ter Berg JW; Merkus FW
    Eur J Clin Pharmacol; 1999 Nov; 55(9):677-80. PubMed ID: 10638398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone.
    Simon JA; Robinson DE; Andrews MC; Hildebrand JR; Rocci ML; Blake RE; Hodgen GD
    Fertil Steril; 1993 Jul; 60(1):26-33. PubMed ID: 8513955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal absorption and metabolism of progesterone and 17 beta-estradiol in the rat.
    Bawarshi-Nassar RN; Hussain AA; Crooks PA
    Drug Metab Dispos; 1989; 17(3):248-54. PubMed ID: 2568904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of progesterone enhanced by intranasal spraying.
    David GF; Puri CP; Anand Kumar TC
    Experientia; 1981 May; 37(5):533-4. PubMed ID: 7250331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy.
    Pickar JH; Bon C; Amadio JM; Mirkin S; Bernick B
    Menopause; 2015 Dec; 22(12):1308-16. PubMed ID: 25944519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal absorption of progesterone in women.
    Dalton ME; Bromham DR; Ambrose CL; Osborne J; Dalton KD
    Br J Obstet Gynaecol; 1987 Jan; 94(1):84-8. PubMed ID: 3814560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal absorption of rizatriptan--in vivo pharmacokinetics and bioavailability study in humans.
    Chen J; Jiang XG; Jiang WM; Gao XL; Mei N
    Pharmazie; 2005 Jan; 60(1):39-41. PubMed ID: 15702515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbopol-based gels for nasal delivery of progesterone.
    Rathnam G; Narayanan N; Ilavarasan R
    AAPS PharmSciTech; 2008; 9(4):1078-82. PubMed ID: 18850277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults.
    Henney HR; Sperling MR; Rabinowicz AL; Bream G; Carrazana EJ
    Epilepsy Res; 2014 Sep; 108(7):1204-11. PubMed ID: 24934774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
    Lee WA; Narog BA; Patapoff TW; Wang YJ
    J Pharm Sci; 1991 Aug; 80(8):725-9. PubMed ID: 1791529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal absorption of natural contraceptive steroids in rats-progesterone absorption.
    Hussain AA; Hirai S; Bawarshi R
    J Pharm Sci; 1981 Apr; 70(4):466-7. PubMed ID: 7229970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability of orally and vaginally administered progesterone.
    Norman TR; Morse CA; Dennerstein L
    Fertil Steril; 1991 Dec; 56(6):1034-9. PubMed ID: 1743318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.